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Introduction 
 
In the soft power context, health is increasingly seen as an area that generates particular diplomatic 
benefits because it is ostensibly non-political and can bring both immediate and long-term 
advantages equally to the donor and the recipient country. Since the European Union’s role in the 
international affairs is increasing, the EU is expected to play a central role in global health guided by 
the principles of solidarity, i.e. to provide an equitable and universal access to quality health services.  
 
Some commentators point to a lack of coherence and coordination between EU health and other 
policies1. Also, ambiguities do exist about the scope of national and European competencies in the 
area of health policy2. The role of the smaller member states may be unusually significant as they 
"use the health arena to demonstrate their commitment to the multilateral systems that provide them 
with a voice and allow them a leading role on the global stage”3. Thus, health diplomacy offers an 
intriguing insight into the dynamics in the EU’s approaches to Central Asia, the region that is 
incrementally becoming of interest to Europe. 
 
 
                                                             
 
1 Rollet, V. & Chang, P. (2013). “Is the European Union a global health actor? An analysis of its capacities, involvement and 
challenges”, European Foreign Affairs Review, vol. 18, no. 3: pp. 309-328. 
2 Guy, M. & Sauter, W. (2016). The history and scope of EU health law and policy (Working Paper no. 16-2). University of East 
Anglia: Centre for Competition Policy. 
3 Kickbusch, I. (2013). “21st century health diplomacy: A new relationship between foreign policy and health”. In T. E. Novotny, 
I. Kickbusch & M. Told (eds.), 21st century global health diplomacy (Singapore: World Scientific): p. 14. 
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Research Parameters  
 
Health diplomacy is assumed to be: 
• separate from disaster relief and short-term humanitarian aid; 
• based on long-term objectives that advance the foreign policy goals of the donor country; and 
• responsive to the expressed need of the recipient state. 
 
This paper analyses its use by the EU and its member states in five Central Asian countries: 
Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan. 
 
To find out how health diplomacy is conducted by the EU and individual European states in Central 
Asia, the health-related projects collected from 1999 to 2016 were analysed and classified into the 
following categories (offered by Bourne 1978)4:  
 
1. medical and health-related research, conferences; 
2. workshops, seminars, conferences promoting cooperation;  
3. manpower training and education;  
4. environmental health, food and research;  
5. construction of health facilities; and, 
6. delivery of health services. 
  
Also, the distinction is made between some that are characterised by joint action or ‘partnership’ and 
others that are primarily aid or ‘provision’. Partnership actions seek to harness the synergy of 
collaboration while provision actions address needs primarily identified by the donor.  
 
The data underlying this analysis relies primarily on academic, EU and governmental documentation, 
semi-structured interviews with key informants in Brussels and Astana, as well as direct enquiries to 
relevant ministries and embassies of the member states. 
 
Evidence and Analysis 
 
• Health cooperation between the EU and Central Asian countries can be traced to 1992 as 
humanitarian aid, but since 2007 it has gained new traction with the publication of the EU 
Regional and Country Strategy Papers, where health was addressed officially for the first time. 
Currently, the extent of EU involvement in regional health activities comprises various 
instruments, thematic programmes and joint collaboration with international organisations 
(see Table 1). 
 
• For 2007-2013, the EU Regional Strategy for Assistance to Central Asia allocated an overall 
budget of €673.8 million for bilateral and regional cooperation. Of this, €139.5 million was 
explicitly earmarked for health and social protection with the aim to "bring the legislation and 
practice of the partner countries closer to those of the most important EU policies and 
standards”5. In Kazakhstan, the funding was allocated to support the capacity building 
initiatives of the Ministry of Health to implement the state programme on healthcare reform 
and development; in Uzbekistan, to improve maternal and child health systems; and, in 
Tajikistan, to develop the health management information system. 
 
                                                             
 
4 Bourne, P. G. (1978). ‘A partnership for international health care’, Public Health Report, vol. 93, no. 2: pp. 114-123  
5 European Commission (2011). “European Union – Central Asia Development Cooperation”. Retrieved from 
https://ec.europa.eu/europeaid/sites/devco/files/publication-european-union-central-asia-development-cooperation-
2011_en.pdf  
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• According to the analysis of the research projects under FP, Horizon 2020 and ISTC 
(sponsored by the EU), Kazakhstan, Kyrgyzstan and Tajikistan are the main scientific partners 
involved in 127, 58 and 23 research projects respectively in areas of health (biosafety, life 
sciences) and environment. In research terms, Central Asian scientists are becoming 
increasingly significant participants at the organising by various EU universities and 
institutions conferences, thus widening the geographic scale of scientific networking and 
engagement.  
 
 
Table 1: EU instruments of cooperation with Central Asia 
Name of the instrument Focus 
The Development Cooperation 
Instrument (replaced Technical 
Assistance to the Commonwealth of 
Independent States (TACIS) in 2007) 
supports the health sector through capacity-building programmes, technical 
assistance for health reforms, maternal and child services, prevention of 
diseases, etc. 
The Instrument for Stability  addresses global security and development challenges and provides 
biosafety and biosecurity cooperation with the region, including research 
cooperation via the International Science and Technology Centre (ISTC); 
The Investment Facility for Central Asia allocates EU development grants to implement infrastructure projects in the 
region that have significant positive impact on health 
The Non-State Actors and Local 
Authorities in Development  
aims to support local participation in development, improve governance, and 
facilitate the access to health services 
The Avian and Human Influenza Facility 
(with small EU funding) 
aims to combat the threat of avian and human influenza in Central Asia. 
 
 
• In respect of provision, the EU's principal funding is for humanitarian actions in response to 
natural disasters. Between 1994 and 2015, this amounted to over €222 million. Health 
diplomacy is expressed in such categories as conducting training, construction of health 
facilities, supporting healthcare reforms and delivery of health services (see Table 2). 
 
• Regarding member states’ actions, some, such as Sweden, Estonia, Belgium and the 
Netherlands, afford the region little or no priority in terms of targeted assistance. 
 
• The UK has been engaging with health issues in all the Central Asian states via the 
Department for International Development (DFID) since 1997. It is working on different levels: 
ministerial – by supporting the reforms of the national health strategies; communal – on 
HIV/AIDS and tuberculosis and by strengthening the delivery of medical emergency help; and, 
university – analytical work on health.  
 
• Germany – according to the strategy of Regional Health Sector Strategy for Central Asia (2010), 
where health was stated as the priority area of cooperation with Kyrgyzstan, Tajikistan and 
Uzbekistan – is interested to promote sexual and reproductive health and rights, to prevent 
HIV and tuberculosis and to improve the efficiency and quality of the health systems. 
 
• Although France does not perceive Central Asia as a high priority6, the French Agency of 
Development started its work in Central Asia in January 2017 in Uzbekistan. Its primary 
concern is climate change and waste management7. 
 
                                                             
 
6 Peyrouse, S. (2012). “France and Central Asia”, EUCAM National Policy Series, vol. 9, retrieved from 
http://fride.org/download/PB9_FR.pdf  
7 AFD (2017). “First financing in Uzbekistan to upgrade waste management in the city of Samarkand”, retrieved from 
http://www.afd.fr/lang/en/home/pays/asie/geo-asie/afd-ouzbekistan  
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• Finland, in its health cooperation with Central Asia, is focused on the gender equity element, 
i.e. on improving women’s access to healthcare.  
 
• Lithuania, Czech Republic, Germany and Slovakia offer academic and practical training 
programmes for medical institutions on various medical issues: obstetrics, gynaecology, 
foetal cardiotocography, eye surgery, diagnosis of cancer, etc. 
 
Table 2: Indicative table on EU assistance to Central Asia*.  
Training 
 
Construction of health facilities 
 
Delivery of health 
services 
Education/Health reforms 
 
Biological and 
Ecological Safety (CIS**, 
2000) 
 
 
 
Creation of Regional Biosafety 
Training Centre in Dushanbe for 
Capacity Building for Tajikistan 
and Afghanistan Professionals 
(2013) 
 
Treatment of 
patients with severe 
burns, Kyrgyzstan 
(2016) 
 
Medical Physics: New ICT-based 
curricula (5 Universities in 
Uzbekistan, 2015-2018) 
 
 
 
Increasing Threat of 
Infectious Diseases 
(CIS, 2001) 
 
 
 
Restoration of 7 blood-
transfusion stations, purchase of 
medical equipment, mobile blood 
donation stations (Kyrgyzstan, 
2016) 
 
 
Modernising health education in 
university (3 Universities in 
Kazakhstan, and 9 Universities in 
Uzbekistan, 2015-2018) 
 
 
Interaction of CIS 
participants in the area 
of Sanitary Monitoring 
(2001) 
Equipment for early laboratory 
diagnosis of echinococcosis/ 
alveococcosis in National 
Surgical Centers in Osh and 
Naryn (Kyrgyzstan, 2016-2018)  
 
 
Advancing university education 
in biomedical engineering and 
health management (7 
Universities in Kyrgyzstan, 2015-
2018) 
 
 
Biosafety and 
Biosecurity Workshop 
for Central Asia and 
Caucasus region (2004) 
 
 
Construction of the National 
perinatal centre in Bishkek 
(Kyrgyzstan, 2016) 
 
 
 
Development of the first national 
standards for the protection of 
motherhood (Kazakhstan, 
Tajikistan, Turkmenistan, 2012-
2015) 
 
Transportation of 
Infectious Substances, 
Animal Biosafety and 
Facilities, Serological 
Methods of 
Investigation (2009-
2010, Kazakhstan) 
 
Construction of feldsсher points 
in Kyrgyzstan (2014) 
 
 
 
 
 
Development of the first 
accreditation standards for the 
protection of motherhood 
(Kazakhstan, Tajikistan, 
Turkmenistan, 2012-2015) 
 
 
International Workshop 
on Probiotics & Health 
(2010, CIS) 
 
Construction of the central 
district hospital in Yavan 
(Tajikistan, 2014) 
 
 
Equity in health care financing 
and delivery (Kyrgyzstan, 2001-
2005) 
 
* Source: Ministries of Health, ISTC reports 
** CIS – The Commonwealth of Independent States 
 
• Ireland provides indirect funding through its contributions to international agencies and deals 
with Central Asia in the context of EU policy. Similarly, Austrian interest in Central Asia, 
especially in the context of health diplomacy, is slight.  
 
• In addition, individual European universities have strategic partnerships in Central Asia, such 
as those between medical schools in Lund (Sweden) and Karaganda (Kazakhstan)8, and 
similar arrangements between Italian and Kazakh universities.  
                                                             
 
8 Karaganda State Medical University (2016). “The first experience in strategic partnership” (23 August), retrieved from 
http://www.kgmu.kz/en/news/view/1740  
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Policy Implications and Recommendations 
 
If, at the beginning of the EU’s engagement with Central Asia, the focus of cooperation was primarily 
on promoting democracy, rule of law and human rights, from 2007 it became clear that the EU 
broadened the list of ‘soft issues’, now including health. So far, the EU has not become a well-
established health actor in Central Asia. Nevertheless, intensified health engagement is ‘better 
received’ and ‘more visible’ than projects on democratisation that are seen ‘as long-term and often 
ineffective’9. Thus, health initiatives allow the EU to gain more influence in the region and enhance its 
positive image. Both the EU and those member states with an active interest have moved beyond 
short-term humanitarian aid and adopted long-term objectives in line with their expressed foreign 
policy goals. The most effective are those that are seen to respond to the needs of the Central Asian 
states without overtly challenging the established order. Similarly, European health diplomacy needs 
to be politically accountable and purposeful rather than subsumed in a “global health” philanthropic 
narrative. 
 
Recommendations: Improving the Use of Health Diplomacy in Central Asia 
While recognising current asymmetries in capacity, the central recommendation is to position health 
professionals in other countries as partners not merely recipients of aid. More specifically, this brief 
advises: 
 
• Hone initiatives: identifiable “branded” local projects bring greater returns 
• Educational provision: in situ training and accreditation reap substantial dividends 
• Align funding with global initiatives: especially in the case of smaller member states 
• Leverage relationships: alumni; research partners; and, EU health NGO personnel 
• Tailor to local values: being attuned to local political and religious norms adds value 
• Health diplomacy specialist: increase training for diplomatic staff in health 
  
                                                             
 
9 Peyrouse, S. (2014). “How does Central Asia view the EU?” (Working Paper, no. 18). Groningen: Stichting Centre for European 
Security Studies. 
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